SEC Form 3 · accession 0001752864-18-000001
Osmotica Pharmaceuticals plc · OSMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Oct 18, 2018
Accepted (ET)
Oct 18, 2018 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 20,235,297 | D | ||
| Ordinary SharesF1 | holding | — | — | — | 1,182,243 | I | By Self as Sole Manager of Orbit Co-Invest A-1 LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.